These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1239 related items for PubMed ID: 10353824

  • 1. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA, Lu SM, Ding J, Bateman KS, James MN, Anderson S, Song J, Markley JL, Ganz PJ, Saunders CW, Laskowski M.
    Biochemistry; 1999 Jun 01; 38(22):7142-50. PubMed ID: 10353824
    [Abstract] [Full Text] [Related]

  • 2. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
    Qasim MA, Ganz PJ, Saunders CW, Bateman KS, James MN, Laskowski M.
    Biochemistry; 1997 Feb 18; 36(7):1598-607. PubMed ID: 9048543
    [Abstract] [Full Text] [Related]

  • 3. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S, Stouch T, Novotny J.
    J Mol Biol; 1993 Dec 05; 234(3):661-79. PubMed ID: 8254666
    [Abstract] [Full Text] [Related]

  • 4. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
    Qasim MA, Van Etten RL, Yeh T, Saunders C, Ganz PJ, Qasim S, Wang L, Laskowski M.
    Biochemistry; 2006 Sep 26; 45(38):11342-8. PubMed ID: 16981694
    [Abstract] [Full Text] [Related]

  • 5. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS, Huang K, Anderson S, Lu W, Qasim MA, Laskowski M, James MN.
    J Mol Biol; 2001 Jan 26; 305(4):839-49. PubMed ID: 11162096
    [Abstract] [Full Text] [Related]

  • 6. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
    Huang K, Lu W, Anderson S, Laskowski M, James MN.
    Protein Sci; 1995 Oct 26; 4(10):1985-97. PubMed ID: 8535235
    [Abstract] [Full Text] [Related]

  • 7. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W, Apostol I, Qasim MA, Warne N, Wynn R, Zhang WL, Anderson S, Chiang YW, Ogin E, Rothberg I, Ryan K, Laskowski M.
    J Mol Biol; 1997 Feb 21; 266(2):441-61. PubMed ID: 9047374
    [Abstract] [Full Text] [Related]

  • 8. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J, Jaskólski M, Buczek O, Cierpicki T, Czapińska H, Krowarsch D, Smalas AO, Stachowiak D, Szpineta A, Dadlez M.
    Acta Biochim Pol; 2001 Feb 21; 48(2):419-28. PubMed ID: 11732612
    [Abstract] [Full Text] [Related]

  • 9. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
    Krowarsch D, Dadlez M, Buczek O, Krokoszynska I, Smalas AO, Otlewski J.
    J Mol Biol; 1999 May 28; 289(1):175-86. PubMed ID: 10339415
    [Abstract] [Full Text] [Related]

  • 10. What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes?
    Laskowski M, Qasim MA.
    Biochim Biophys Acta; 2000 Mar 07; 1477(1-2):324-37. PubMed ID: 10708867
    [Abstract] [Full Text] [Related]

  • 11. Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues.
    Bigler TL, Lu W, Park SJ, Tashiro M, Wieczorek M, Wynn R, Laskowski M.
    Protein Sci; 1993 May 07; 2(5):786-99. PubMed ID: 8495199
    [Abstract] [Full Text] [Related]

  • 12. NMR determination of pKa values for Asp, Glu, His, and Lys mutants at each variable contiguous enzyme-inhibitor contact position of the turkey ovomucoid third domain.
    Song J, Laskowski M, Qasim MA, Markley JL.
    Biochemistry; 2003 Mar 18; 42(10):2847-56. PubMed ID: 12627950
    [Abstract] [Full Text] [Related]

  • 13. Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.
    Czapinska H, Helland R, Smalås AO, Otlewski J.
    J Mol Biol; 2004 Dec 03; 344(4):1005-20. PubMed ID: 15544809
    [Abstract] [Full Text] [Related]

  • 14. Alanine point-mutations in the reactive region of bovine pancreatic trypsin inhibitor: effects on the kinetics and thermodynamics of binding to beta-trypsin and alpha-chymotrypsin.
    Castro MJ, Anderson S.
    Biochemistry; 1996 Sep 03; 35(35):11435-46. PubMed ID: 8784199
    [Abstract] [Full Text] [Related]

  • 15. Computational analysis of the binding of P1 variants of domain 3 of turkey ovomucoid inhibitor to Streptomyces griseus protease B.
    Fujinaga M, Huang K, Bateman KS, James MN.
    J Mol Biol; 1998 Dec 18; 284(5):1683-94. PubMed ID: 9878379
    [Abstract] [Full Text] [Related]

  • 16. X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution.
    Bolognesi M, Pugliese L, Gatti G, Frigerio F, Coda A, Antolini L, Schnebli HP, Menegatti E, Amiconi G, Ascenzi P.
    J Mol Recognit; 1990 Aug 18; 3(4):163-8. PubMed ID: 2278733
    [Abstract] [Full Text] [Related]

  • 17. The crystal structures of the complexes between bovine beta-trypsin and ten P1 variants of BPTI.
    Helland R, Otlewski J, Sundheim O, Dadlez M, Smalås AO.
    J Mol Biol; 1999 Apr 16; 287(5):923-42. PubMed ID: 10222201
    [Abstract] [Full Text] [Related]

  • 18. Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain.
    Lu W, Qasim MA, Laskowski M, Kent SB.
    Biochemistry; 1997 Jan 28; 36(4):673-9. PubMed ID: 9020764
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of the bovine alpha-chymotrypsin:Kunitz inhibitor complex. An example of multiple protein:protein recognition sites.
    Capasso C, Rizzi M, Menegatti E, Ascenzi P, Bolognesi M.
    J Mol Recognit; 1997 Jan 28; 10(1):26-35. PubMed ID: 9179777
    [Abstract] [Full Text] [Related]

  • 20. Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases.
    Grzesiak A, Helland R, Smalås AO, Krowarsch D, Dadlez M, Otlewski J.
    J Mol Biol; 2000 Aug 04; 301(1):205-17. PubMed ID: 10926503
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 62.